Skip to main content
. 2014 Nov 11;7:321–327. doi: 10.2147/CCID.S69240

Table 5.

“Change of conditions” results from psoriasis patients group

Psoriasis group
Bosexil® Vaccinium myrtillus seed oil Placebo
Erythema
 In remission 0 30 0
 Improved 60 10 0
 Unchanged 40 60 90
 Worsened 0
P=0.0281
0
P=0.253*
10
Scales
 In remission 0 0 0
 Improved 70 80 0
 Unchanged 30 20 100
 Worsened 0
P=0.001
0
P=0.0003
0

Notes:

*

P-value is related to 40% positive response given by the addition in remission (30%) + improved (10%). All values are represented as percentages.